Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.
Chronic hepatitis C virus (HCV) infection is one of the leading causes of liver failure and liver cancer, affecting around 3% of the world's population. The extreme sequence variability of the virus resulting from error-prone replication has thwarted the discovery of a universal prophylactic vaccine. It is known that vigorous and multispecific cellular immune responses, involving both helper CD4(+) and cytotoxic CD8(+) T cells, are associated with the spontaneous clearance of acute HCV infection. Escape mutations in viral epitopes can, however, abrogate protective T-cell responses, leading to viral persistence and associated pathologies. Despite the propensity of the virus to mutate, there might still exist substitutions that incur a fitness cost. In this paper, we identify groups of coevolving residues within HCV nonstructural protein 3 (NS3) by analyzing diverse sequences of this protein using ideas from random matrix theory and associated methods. Our analyses indicate that one of these groups comprises a large percentage of residues for which HCV appears to resist multiple simultaneous substitutions. Targeting multiple residues in this group through vaccine-induced immune responses should either lead to viral recognition or elicit escape substitutions that compromise viral fitness. Our predictions are supported by published clinical data, which suggested that immune genotypes associated with spontaneous clearance of HCV preferentially recognized and targeted this vulnerable group of residues. Moreover, mapping the sites of this group onto the available protein structure provided insight into its functional significance. An epitope-based immunogen is proposed as an alternative to the NS3 epitopes in the peptide-based vaccine IC41.


OBJECTIVE
Despite much experimental work on HCV, a thorough statistical study of the HCV sequences for the purpose of immunogen design was missing in the literature. Such a study is vital to identify epistatic couplings among residues that can provide useful insights for designing a potent vaccine. In this work, ideas from random matrix theory were applied to characterize the statistics of substitutions within the diverse publicly available sequences of the genotype 1a HCV NS3 protein, leading to a group of sites for which HCV appears to resist simultaneous substitutions possibly due to deleterious effect on viral fitness. Our analysis leads to completely novel immunogen designs for HCV. In addition, the NS3 epitopes used in the recently proposed peptide-based vaccine IC41 were analyzed in the context of our framework. Our analysis predicts that alternative NS3 epitopes may be worth exploring as they might be more efficacious.
Department of Electronic and Computer Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong.
Ahmed A
AA
Quadeer
Department of Electronic and Computer Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong.
Raymond H Y
RH
Louie
Department of Chemical Engineering, MIT, Cambridge, Massachusetts, USA Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Boston, Massachusetts, USA.
Karthik
K
Shekhar
Department of Chemical Engineering, MIT, Cambridge, Massachusetts, USA Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Boston, Massachusetts, USA Department of Physics, MIT, Cambridge, Massachusetts, USA Department of Chemistry, MIT, Cambridge, Massachusetts, USA Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA Institute for Medical Engineering and Science, MIT, Cambridge, Massachusetts, USA Institute for Advanced Study, HKUST, Clear Water Bay, Kowloon, Hong Kong.
Arup K
AK
Chakraborty
Department of Chemical and Biomolecular Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong Division of Biomedical Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong.
I-Ming
IM
Hsing
Department of Electronic and Computer Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong Division of Biomedical Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong eemckay@ust.hk.
Matthew R
MR
McKay
D019943:Amino Acid Substitution; D003627:Data Interpretation, Statistical; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics* / Q000302:isolation & purification; D006526:Hepatitis C / Q000276:immunology* / Q000821:virology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D016056:Immunodominant Epitopes / Q000276:immunology*; D009154:Mutation / Q000235:genetics; D011487:Protein Conformation; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
D016056:Immunodominant Epitopes; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases